Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2020, Vol. 47 Issue (5): 785-788    DOI: 10.31083/j.ceog.2020.05.5367
Case Report Previous articles | Next articles
Placenta accreta and uterine rupture of unscarred uterus in patients with systemic lupus erythematosus with prolonged steroid exposure: a report of two cases
H.M. Kim1, Y.J. Chin1, H.H. Cha1, W.J. Seong1, M.J. Kim1, *()
1Department of Obstetrics and Gynecology, Kyungpook National University Hospital, Kyungpook National University, School of Medicine, Daegu, Republic of Korea
Download:  PDF(522KB)  ( 133 ) Full text   ( 8 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

We experienced two cases of placental abnormalities or uterine rupture in patients with systemic lupus erythematosus (SLE), necessitating cesarean hysterectomy and leading to massive hemorrhage that required large transfusions. So we introduced the possibility of abnormal placentation and uterine rupture as well as preeclampsia, preterm labor, and fetal growth restriction needs to be considered in pregnant women with SLE who have been taking steroids, even if low dose, for prolonged periods and who do not have any other risk factors.

Key words:  Lupus      Uterine rupture      Placenta accrete      Steroid     
Submitted:  10 September 2019      Accepted:  05 May 2020      Published:  15 October 2020     
*Corresponding Author(s):  M.J. Kim     E-mail:  ties1004@naver.com

Cite this article: 

H.M. Kim, Y.J. Chin, H.H. Cha, W.J. Seong, M.J. Kim. Placenta accreta and uterine rupture of unscarred uterus in patients with systemic lupus erythematosus with prolonged steroid exposure: a report of two cases. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 785-788.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2020.05.5367     OR     https://ceog.imrpress.com/EN/Y2020/V47/I5/785

Figure 1.  — In case 1, the patient complained of increasing abdominal pain, and repeat ultrasound revealed increased intra-abdominal fluid collection that was interpreted as hemoperitoneum (with up to 50 cc of fluid).

Figure 2.  — In case 1, a gross photo of the uterus. After fetal delivery, it was difficult to remove the placenta. Upon checking the uterus, we found a small (approximately 2 cm) hole (arrow) in the uterine fundus, revealing uterine rupture that was the focus of the hemoperitoneum.

[1] Lateef A., Petri M.: “Systemic lupus erythematosus and pregnancy”. Rheum. Dis. Clin. N. Am., 2017, 43, 215-226.
doi: 10.1016/j.rdc.2016.12.009
[2] Georgiou P.E., Politi E.N., Katsimbri P., Sakka V., Drosos A.A.: “Outcome of lupus pregnancy: a controlled study”. Rheumatology, 2000, 39, 1014-1019.
doi: 10.1093/rheumatology/39.9.1014 pmid: 10986308
[3] Rahman P., Gladman D.D., Urowitz M.B.: “Clinical predictors of fetal outcome in systemic lupus erythematosus”. J. Rheumatol., 1998, 25, 1526-1530.
pmid: 9712095
[4] Mittal N., Pineda M., Lim B., Carey E.: “Placenta previa increta in an unscarred uterus with marked thinning of myometrium in the entire uterus in a patient with systemic lupus erythematosus”. Int. J. Gynecol. Pathol., 2018, 37, 198-203.
doi: 10.1097/PGP.0000000000000397 pmid: 28463907
[5] Noh J.J., Park C.H., Jo M.H., Kwon J.Y.: “Rupture of an unscarred uterus in a woman with long-term steroid treatment for systemic lupus erythematosus”. Obstet. Gynecol., 2013, 122, 472-475.
doi: 10.1097/AOG.0b013e3182998fb6
[6] Wortman A.C., Alexander J.M.: “Placenta accreta, increta, and percreta”. Obstet. Gynecol. Clin. North. Am., 2013, 40, 137-154.
doi: 10.1016/j.ogc.2012.12.002 pmid: 23466142
[7] Publications Committee, Society for Maternal-Fetal Medicine; Belfort M.A.: “Placenta accreta”. Am. J. Obstet. Gynecol., 2010, 203, 430-439.
doi: 10.1016/j.ajog.2010.09.013 pmid: 21055510
[8] Cortes-Hernandez J., Ordi-Ros J., Paredes F., Casellas M., Castillo F., Vilardell-Tarres M.: “Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies”. Rheumatology, 2002, 41, 643-650.
doi: 10.1093/rheumatology/41.6.643 pmid: 12048290
[9] Kiss E., Bhattoa H.P., Bettembuk P., Balogh A., Szegedi G.: “Pregnancy in women with systemic lupus erythematosus”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2002, 101, 129-134.
doi: 10.1016/s0301-2115(01)00525-5 pmid: 11858886
[10] Rabin D.S., Johnson E.O., Brandon D.D., Liapi C., Chrousos G.P.: “Glucocorticoids inhibit estradiol-mediated uterine growth: possible role of uterine estradiol receptor”. Biol. Reprod., 1990, 42, 74-80.
doi: 10.1095/biolreprod42.1.74 pmid: 2310819
[11] Kelly F.J., Goldspink D.F.: “The differing responses of four muscle types to dexamethasone treatment in the rat”. Biochem. J., 1982, 208, 147-151.
doi: 10.1042/bj2080147 pmid: 6186244
[12] Lash G.E., Bulmer J.N., Innes B.A., Drury J.A., Robinson S.C., Quenby S.: “Prednisolone treatment reduces endometrial spiral artery development in women with recurrent miscarriage”. Angiogenesis, 2011, 14, 523-532.
doi: 10.1007/s10456-011-9237-x
[13] Tomimatsu T., Hazama Y., Takeuchi M., Kimura T., Shimoya K.: “Unresponsiveness to oxytocin due to an extremely thin uterine wall in a pregnant woman with systemic lupus erythematosus and Sjogren’s syndrome”. J. Obstet. Gynaecol., 2018, 38, 276-278.
doi: 10.1080/01443615.2017.1340439 pmid: 28830255
[1] Valeria Filippi, Luigi Raio, Sophia Amylidi-Mohr, Rudolf Tschudi, Daniele Bolla. Epidural analgesia at trial of labour after caesarean section. A retrospective cohort study over 12 years[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 913-917.
[2] Ji Eun Park, Ji Kwon Park, Hyun Chul Jo, In Ae Cho, Jong Chul Baek. The association between antenatal corticosteroid use in late-preterm and early-term pregnancy and nonreassuring fetal status[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 79-84.
[3] X.Y. Zhou, K.X. Li, X.M. Shu. Analysis and discussion of high-risk factors in nine cases of uterine scar combined with complete uterine rupture[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 769-773.
[4] Li Li Zhang, Hua Shu, Shuai Zhang, Tian Tian Wang, Lan Lan Zhang. Pregnancy outcomes and risk factors in pregnant women with systemic lupus erythematosus[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 189-193.
[5] H.A. Mansouri. Do bone turnover markers change with a steep drop in maternal steroids?[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 784-786.
[6] X. Lu, Q. Tian, S. Zhou, S. Zhang, X. Sun, G. Tian. Acute hemoperitoneum in third trimester: two case reports[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 821-823.
[7] E. Panagiotou, P. Tsikouras, A. Bothou, S. Fotopoulos, S. Zervoudis, D. Deuteraiou, A. B. Chalil, G. Trypsianis, G. Galazios. A comparative study of the contribution of antenatal corticosteroids administration on improving neonatal respiratory function after elective cesarean section[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 368-374.
[8] Erqiu Du, Yongmei Li, Li Shang, Yongli Chen, Xia Gao, Xueying Duan. Uterine rupture in twin pregnancy complicated with herniation of amniotic sac and umbilical cord: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 333-334.
[9] Jing Fu, Na Hu, Lin Qiao, Qiang Yao. Cornual pregnancy with placenta percreta and uterine rupture at 19 weeks' gestation[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 141-142.
[10] C. Theofanakis, L. Michala, A. Karampelas, S.N. Al-Achmar, G. Daskalakis. Second trimester uterine rupture in a septated unscarred uterus: a case report study[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 599-601.
[11] Sun Young Jung, Suk Young Kim. Is it possible to early diagnose uterine rupture by ultrasound without common clinical signs during pregnancy following laparoscopic myomectomy?[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 605-607.
[12] Ning Hui, Xiuli Li, Shujuan Wang, Yuanguang Meng, Yuan Gao. A third-trimester rupture in a scarred uterus: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 452-455.
[13] H.S.O. Abduljabbar, A.K. Agabawi, M. Assiri, M.S. Akel, A.M. Oraif. Uterine rupture: a five-year experience at a tertiary care centre in Jeddah, Saudi Arabia[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 178-181.
[14] F. Yuling, A. Tiekui, S. Qifang. Successful pregnancy after repairing of unscarred uterine rupture during midtrimester: case study and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 123-125.
[15] K.P. Fuller, S. DeGroff, A.F. Borgida. Neonatal outcomes based on antenatal corticosteroid exposure time for infants delivered between 23 and 34 weeks gestation[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(2): 247-251.
No Suggested Reading articles found!